Berkeley, CA, United States of America

Uri Lopatin

This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Pardes Biosciences, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uri Lopatin. Retrieved from https://idiyas.com/inventor/uri-lopatin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Uri Lopatin: Inventor in Protease Inhibitor Research

Introduction

Uri Lopatin is an inventor based in Berkeley, California. His patent work concerns compounds designed to inhibit cysteine proteases, including proteases associated with viral infections.

Latest Patents

The provided information lists one patent for Lopatin: “Inhibitors of Cysteine Proteases and Methods of Use Thereof.” The disclosure describes compounds with warheads, pharmaceutical compositions, and methods for making the compounds. It also discusses their potential use in treating medical diseases or disorders, including viral infections, by inhibiting proteases such as 3C, CL, or 3CL-like proteases. The listed patent count is 1 patent.

Career Highlights

Lopatin has been associated with Pardes Biosciences, Inc. and F. Hoffmann-La Roche AG. His listed patent reflects work focused on protease inhibition and potential therapeutic applications.

Collaborations

The provided information names Lee D. Arnold and Walter Keung as Lopatin’s coworkers.

Conclusion

Uri Lopatin’s listed invention centers on protease-inhibiting compounds and their potential use in developing treatments for viral infections and other medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…